Organization Profile

You just read:

Pivotal Therapeutics VASCAZEN® - Meets Primary Endpoint in Reveal Trial - Top Line Results Accepted for Presentation at the American Heart Association's ATVB 2013 Scientific Sessions

News provided by

Pivotal Therapeutics Inc.

Apr 09, 2013, 08:45 ET